We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Clinical Effects of a Nucleotides-Supplemented Infant Formula

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00292812
Recruitment Status : Completed
First Posted : February 16, 2006
Last Update Posted : October 23, 2007
Information provided by:

Study Description
Brief Summary:
The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.

Condition or disease Intervention/treatment
Nutritional Requirements Drug: Nutritional supplementation (nucleotides)

Detailed Description:

Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will be monitored prospectively for the following outcome parameters:

  • Growth percentiles.
  • Behaviour and infantile colic.
  • Bowel habits.
  • Side effects.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides
Study Start Date : March 2006
Study Completion Date : October 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. Growth percentiles, Behaviour and infantile colic, Bowel habits.

Secondary Outcome Measures :
  1. Side effects.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 30 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy newborns aged 0-30 days.

Exclusion Criteria:

  • Prematurity
  • Chronic illness
  • Failure to thrive
  • Milk allergy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00292812

Soroka Medical Center
Beer-Sheva, Israel, 84101
Sponsors and Collaborators
Soroka University Medical Center
Materna Laboratories
Principal Investigator: Zvi Weizman, MD Head, Pediatric GI and Nutrition Unit
More Information

ClinicalTrials.gov Identifier: NCT00292812     History of Changes
Other Study ID Numbers: Sor4123ctil
First Posted: February 16, 2006    Key Record Dates
Last Update Posted: October 23, 2007
Last Verified: May 2007

Keywords provided by Soroka University Medical Center:
Infant nutrition
Infant formula